Theres growing evidence suggesting a positive role of GLP-1 agonists in managing polycystic ovary syndrome (PCOS) and non-alcoholic fatty liver disease (NAFLD), providing new avenues for addressing these difficult-to-treat disorders
Scorpion venomics: a 2019 overview
He explores how health priorities and strategies should evolve across different decades of life, which chronic diseases are most challenging to manage and how to think about risk hierarchies, and which emerging interventionsbeyond exerciseshow the most promise for dementia prevention
Park SW, Mansur RB, Lee Y, Lee JH, Seo MK, Choi AJ, et al
What is the difference between Saxenda and Wegovy
Jiang T, Cheng H, Su J, Wang X, Wang Q, Chu J, et al